 |
|
Drug helps cognitive function in brain tumor patients after radiation
March 20, 2006WINSTON-SALEM, N.C. - A drug that is marketed to treat Alzheimer's disease also improves cognitive function, mood and quality of life in brain tumor patients following radiation therapy, according to a research team at Wake Forest University Baptist Medical Center.
After the patients were treated for six months with donepezil (trade name: Aricept), there was a significant improvement in their symptoms, the researchers reported in the March 17 issue of the Journal of Clinical Oncology.
"Each year more than 15,000 Americans are diagnosed with a primary brain tumors, and as many as 200,000 with metastatic brain tumors, nearly all of whom receive radiation therapy," said Edward G. Shaw, M.D. "For survivors of brain tumor radiation, symptoms of short-term memory loss and mood changes similar to those seen in Alzheimer's disease, as well as fatigue, frequently occur, leading to a poor quality of life."
Donepezil, part of a class of drugs called acetylcholinesterase (AChE) inhibitors, "has demonstrated efficacy in mild to severe Alzheimer's disease and vascular dementia," said Stephen R. Rapp, Ph.D., professor of psychiatry and behavioral medicine and senior author on the paper. It is approved by the U.S. Food and Drug Administration for that purpose.
"The results of this initial study encourage continued investigation of donepezil and other AChE inhibitors," Rapp said.
The research team is planning a clinical trial in which treatment of brain tumor patients with donepezil will be compared to an inert placebo, and neither the doctor nor the patient will know which pill they received until the study is completed.
"To our knowledge, this is the first study of an AChE inhibitor or any other drug administered to long-term survivors of partial or whole brain radiation therapy in an attempt to reduce the symptoms associated with a brain tumor and its treatments," said Shaw, professor and chairman of the Department of Radiation Oncology and a co-author.
"The pretreatment assessment of thinking, memory, mood and energy level revealed symptoms that clearly affected quality of life," Shaw said.
The researchers decided to try donepezil after observing that radiation-induced brain injury resembles Alzheimer's disease and other forms of dementia not only in the clinical symptoms but also in what is seen with brain imaging, particularly with magnetic resonance imaging (MRI) and positron emission tomography (PET).
The team hypothesized that radiation therapy for brain tumors resulted in injury to neurons that in turn caused a deficiency of a brain chemical called acetylcholine. They thought use of an AChE inhibitor - such as donepezil - might increase the acetylcholine level in the brain, decrease cognitive symptoms and improve mood and quality of life. Their study indicated it did.
"Additional research is needed to further evaluate donepezil and other AChE inhibitors in this population." Rapp said.
The other members of the team were Robin Rosdhal, R.N., O.C.N., and Mike E. Robbins, Ph.D., both from radiation oncology, and Ralph B. D'Agostino Jr., Ph.D., James Lovato, M.S. and Michelle J. Naughton, Ph.D., all from public health sciences.
Wake Forest University Baptist Medical Center
Donepezil, part of a class of drugs called acetylcholinesterase (AChE) inhibitors, "has demonstrated efficacy in mild to severe Alzheimer's disease and vascular dementia," said Stephen R. Rapp, Ph.D., professor of psychiatry and behavioral medicine and senior author on the paper. It is approved by the U.S. Food and Drug Administration for that purpose.
"The results of this initial study encourage continued investigation of donepezil and other AChE inhibitors," Rapp said.
The research team is planning a clinical trial in which treatment of brain tumor patients with donepezil will be compared to an inert placebo, and neither the doctor nor the patient will know which pill they received until the study is completed.
"To our knowledge, this is the first study of an AChE inhibitor or any other drug administered to long-term survivors of partial or whole brain radiation therapy in an attempt to reduce the symptoms associated with a brain tumor and its treatments," said Shaw, professor and chairman of the Department of Radiation Oncology and a co-author.
"The pretreatment assessment of thinking, memory, mood and energy level revealed symptoms that clearly affected quality of life," Shaw said.
The researchers decided to try donepezil after observing that radiation-induced brain injury resembles Alzheimer's disease and other forms of dementia not only in the clinical symptoms but also in what is seen with brain imaging, particularly with magnetic resonance imaging (MRI) and positron emission tomography (PET).
The team hypothesized that radiation therapy for brain tumors resulted in injury to neurons that in turn caused a deficiency of a brain chemical called acetylcholine. They thought use of an AChE inhibitor - such as donepezil - might increase the acetylcholine level in the brain, decrease cognitive symptoms and improve mood and quality of life. Their study indicated it did.
"Additional research is needed to further evaluate donepezil and other AChE inhibitors in this population." Rapp said.
The other members of the team were Robin Rosdhal, R.N., O.C.N., and Mike E. Robbins, Ph.D., both from radiation oncology, and Ralph B. D'Agostino Jr., Ph.D., James Lovato, M.S. and Michelle J. Naughton, Ph.D., all from public health sciences.
Wake Forest University Baptist Medical Center
Cognitive Function Current Events and Cognitive Function News RSSSurgery not linked to memory problems in older patients
For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions.
Mood improves on low-fat, but not low-carb, diet plan
After one year, a low-calorie, low-fat diet appears more beneficial to dieters' mood than a low-carbohydrate plan with the same number of calories.
Reduced muscle strength associated with risk for Alzheimer's
Individuals with weaker muscles appear to have a higher risk for Alzheimer's disease and declines in cognitive function over time, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.
Preventative brain radiation for lung cancer patients: Benefits and risks
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Caltech researchers show efficacy of gene therapy in mouse models of Huntington's disease
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.
Benefit of memantine in the treatment of Alzheimer's disease not proven
There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine.
Fighting Sleep, Penn Researchers Reverse the Cognitive Impairment Caused By Sleep Deprivation
A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation.
First-time Internet users find boost in brain function after just 1 week
You can teach an old dog new tricks, say UCLA scientists who found that middle-aged and older adults with little Internet experience were able to trigger key centers in the brain that control decision-making and complex reasoning after just one week of surfing the Web.
Overweight middle-aged women cut chances of enjoying healthy old age
Women who put on weight as they approach middle-age could reduce their chances of enjoying a healthy old age by up to 80%, according to research from the University of Warwick.
Artificial intelligence helps diagnose cardiac infections
Mayo Clinic researchers say that "teachable software" designed to mimic the human brain may help them diagnose cardiac infections without an invasive exam.
More Cognitive Function Current Events and Cognitive Function News Articles
|
The Development and Neural Bases of Higher Cognitive Functions (Annals of the New York Academy of Sciences) by Adele Diamond (Editor) | |
 |
Procognin Increased concentration & cognitive function (3) Bottles 120 Capsules in each Bottle by MicroNutra Procognin provides a long list of natural vitamins, minerals, and herbs that have been scientifically researched to promote optimal memory and cognitive function. If you forget names, misplace your possessions, or can't recall inporntant details, dont just chalk it up to aging. You can try Procognin risk-free! Enjoy reliving your memories and making new ones every day with Procognin. Let Procognin help you today. |
 |
Novifit S 100 mg, 30 Tablets by Virbac Animal Health Novifit S helps support cognitive function of aging dogs and cats. Novifit S is a highly pure and stable form of SAMe (NoviSAMe) presented in an enteric-coated tablet. |
 |
Olympian Labs Chromium Polynicotinate, Chromemate, 200mcg (Pack of 2) by Olympian Labs Chromium was first recognized as an important dietary trace mineral in the 1950s. Research discovered that it works with insulin to help metabolize carbohydrates, fats and proteins. Insulin depends on chromium to help move sugar and fat into the body’s cells, where the nutrients either are burned for fuel or stored. Although essential to metabolic function, chromium is not produced by the body and must be included in the diet. Foods rich in chromium - such as mushrooms, broccoli, brewer’s yeast, brown rice, cheese, meat and wheat germ - often are not consumed at levels high enough to supply recommended levels of the nutrient. Chromium forms part of a compound in the body known as glucose tolerance factor (GTF), which is involved in regulating the action of insulin in maintaining blood... |
 |
Cognitive Changes with Aging: What Can You Expect? This lecture focuses on memory problems people face and their correlation to problems later in life. Also discussed: when is testing appropriate, benefits of early testing, what the tests involve and what they mean, decision-making and cognition, and appropriate interventions. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Thy Will Be Done Also With: WB (Producer) |
 |
Olympian Labs Acetyl L-carnitine, 500mg by Olympian Labs Acetyl-L-Carnitine is the ester form of L-Carnitine; a naturally occurring amino acid metabolized from Lysine and Methionine and used extensively by the brain and nervous system. There is a significant amount of research on L-Carnitine's role in cardiac and skeletal muscle function and in its role in fat metabolism/loss. N-Acetyl- L-Carnitine's research has focused mainly on its role in brain and nervous system function with regard to the aging process. The older we get, the more likely we are to suffer from cognitive/memory loss. Many nutrients have been studied for their potential in promoting brain health in older adults. N-Acetyl-L-Carnitine is one of those nutrients. N-Acetyl-L-Carnitine is involved in preventing age-related effects on the brain by protecting neurons from oxidative... |
 |
The Prefrontal Cortex: Executive and Cognitive Functions by A. C. Roberts (Editor), T. W. Robbins (Editor), L. Weiskrantz (Editor) The prefrontal cortex, one of the most important areas of research in contemporary neuropsychology, appears to be linked with executive processes affecting many diverse areas of cognition, including working memory, information processing, behavioral organization, and attention. This state-of-the-art account of our knowledge of the prefrontal cortex brings together contributions from some of the world's leading researchers on the subject. The authors discuss the many recent theoretical and technical advances in the field--from advances in our understanding of the neural architecture of the prefrontal cortex to the use of functional neuroimaging and from new ideas about the relationships between neuronal activity and behavior to comparisons between human and non-human primate cognition. One... |
 |
Cognitive and Perceptual Rehabilitation: Optimizing Function by Glen Gillen EdD OTR FAOTA (Author) Reflecting current practice with a renewed focus on function-based assessments and evidence-based interventions, Cognitive and Perceptual Rehabilitation: Optimizing Function includes all of the tools you need to make a positive impact on your patients' lives. This clinical resource summarizes, highlights, and constructively critiques the state of cognitive and perceptual rehabilitation. This text helps you enhance your patients' quality of life by promoting improved performance of necessary and meaningful activities, and decreasing participation restrictions. Evidence-based intervention tables focus on improving daily function through proven methods.Summary tables highlight each assessment's clinical utility and pyschometric properties to provide you with the tools you need to... |
|
The Basic Mental Status Examination Series: Evaluating Intellectual and Cognitive Function [VHS] Starring: Intercollegiate Center for Nursing Education |
| © 2009 BrightSurf.com |